Table 1 Clinical variables difference between NBNC-HCC and HBV-HCC

Sample size

68

107

Age, years

50.72 ± 11.90

47.09 ± 11.36

AFP, ng/mL

13,734.7 ± 46,337.2

10,729.2 ± 23,103.5

Gender

 Male

58 (85.3%)

98 (91.6%)

 Female

10 (14.7%)

9 (8.4%)

Cirrhosis

 Yes

56 (82.4%)

93 (86.9%)

vNo

12 (17.6%)

14 (13.1%)

Tumor size, cm

  < 5

11 (16.2%)

17 (15.9%)

  ≥ 5

57 (83.8%)

90 (84.1%)

Differentiation

 Well-moderate

42 (61.8%)

74 (69.2%)

 Poor-undifferentiated

26 (38.2%)

33 (30.8%)

TNM stage

 I–II

37 (54.4%)

50 (46.7%)

vIII–IV

31 (45.6%)

57 (53.3%)

Vascular invasion

 Yes

7 (10.3%)

25 (23.4%)

 No

61 (89.7%)

82 (76.6%)